EnteroBiotix is a clinical-stage microbiome therapeutics company focused on developing treatments for gastrointestinal diseases and immune-related disorders. Utilizing proprietary microbial consortia and advanced formulation technologies, EnteroBiotix aims to restore gut health, modulate the immune system, and deliver safe, effective, and scalable microbiome-based therapies to patients worldwide.